PLAU and prostate carcinoma: The combination of uPA, uPA receptor and PAI is crucial in the modulation of ECM homeostasis and tumour invasion as demonstrated in breast and prostate cancer cells [30], [31] and oesophageal adenocarcinoma cells made to over-express uPA in vitro[11].